Coexistence of acquired hemophilia A and epidermolysis bullosa acquisita: Two case reports and published work review

详细信息    查看全文

• 作者：Tian-Meng Yan ; Chun-Xia He ; Bao-Lai Hua ; Li Li ; Hong-Zhong Jin ; Yue-Hua Liu and Ya-Gang Zuo
• 刊名：The Journal of Dermatology
• 出版年：2017
• 出版时间：January 2017
• 年：2017
• 卷：44
• 期：1
• 页码：76-79
• 全文大小：395K
• ISSN：1346-8138

文摘

Epidermolysis bullosa acquisita (EBA) is a rare chronic subepidermal bullous autoimmune disease. The occurrence of acquired hemophilia A (AHA) is low and so the coexistence of EBA and AHA is extremely rare. We herein described a case of EBA coexisting with AHA and a case of EBA coexisting with AHA and hepatitis B. These EBA may be related to the pathogenesis of AHA. In this study, we analyzed the clinical features in the two Chinese cases of EBA coexisting with AHA, and found esophageal hemorrhage and hematemesis were the main symptoms of both patients. Cyclosporin, prednisone and lamivudine effectively control EBA with AHA and hepatitis B. The dose of cyclosporin should be more than 4 mg/kg per day and the period of treatment should be longer than 5 months to reduce the risk of EBA co-occurring with AHA.